Amit Dayal

In a report issued Wednesday, H.C. Wainwright analyst Amit Dayal reiterated a Buy rating and $21.00 price target on shares of Second Sight Medical Products Inc (NASDAQ: EYES). The reiteration comes after the company announced the first implant and successful activation of the Argus II Retinal...

In a report published Thursday, Rodman & Renshaw analyst Amit Dayal initiated coverage of Digital Ally, Inc. (NASDAQ: DGLY) with a Buy rating and $24 price target. The company has been able to achieve an industry leading position through its consistent innovations. The spend on security system...

In a report published Friday, H.C. Wainwright analyst Amit Dayal reiterated a Buy rating on RADCOM Ltd. (NASDAQ: RDCM), and raised the price target from $7.50 to $13.50. In the report, H.C. Wainwright noted, “We are increasing our price target on RDCM to $13.50 from $7.50 previously. This upward...

In a report published Thursday, H.C. Wainwright & Co. analyst Amit Dayal initiated coverage on Finjan Holdings, Inc. (NASDAQ: FNJN) with a Buy rating and $5.00 price target. In the report, H.C. Wainwright & Co. noted, “We are initiating coverage on Finjan Holdings, Inc. (FNJN) with a Buy...

In a report published Monday, H.C. Wainwright & Co. analyst Amit Dayal initiated coverage on MeetMe (NYSE: MEET) with a Buy/ Speculative Risk rating and $5.00 price target. Dayal noted that MeetMe's audience continued to engage with the platform via mobile. The analyst remarked that this is...